Bayer Czech Republic's total assets reached CZK 1,165 mil at the end of 2017, down 3.71% compared to the previous year.
Current assets amounted to CZK 1,145 mil, or 98.3% of total assets while cash stood at CZK 10.8 mil at the end of 2017.
By contrast, total debt reached CZK 404 mil at the year-end, or 34.7% of total assets, while the firm's equity amounted to CZK 417 mil. As a result, net debt stood at CZK 393 mil at the end of 2017 and accounted for 94.4% of equity.
Net debt against equity is up 98.2 pp from five years ago (-3.80%). The ratio against EBITDA increased from -0.098x seen in 2012 to 2.49x.
The company’s cost of funding amounted to 0.929% in 2017, down 3.30 pp compared to the average over the last 5 years.
You can see all the company’s data at Bayer Czech Republic profile, or you can download a report on the company in the report section.
Helgi Library 
